What is Cytology and Human Papilloma Virus (HPV) Testing?
Cytology also called as cell biology and cytopathology in which study of cell composition, cell structure and the interaction among cells and the environment in which they exist. It also examines the cell structure which helps to diagnose disease. Human papilloma virus (HPV) is group of more than 100 related viruses. They can affect the moist membranes of body part such as anus, vagina, vulva and lining of the mouth and throat. It also affects the skin of human body, trachea, bronchi, inner nose, mouth and inner eyelids. All human papilloma viruses (HPV) in the group are specified a number called an HPV type. The implication of early diagnosis and detection is not lost on them resultant in the improved adoption of these tests such as cytology and HPV testing.
How Big is the Cytology and HPV testing market?
The Cytology and HPV testing market is expected to exceed more than USD 14.7 Billion by 2028. HPV testing market will grow at a CAGR of more than 10% in the given forecast period. While Cytology testing market will grow at a CAGR of around 5% from 2023 to 2028.
The Major Driving factors of cytology and HPV testing market are as follows:
Growing cervical cancer screening awareness plans
High occurrence rate of HPV infections
Increasing the amount of cervical cancer globally
The Restraining factors of Cytology and HPV testing market are as follows:
Low understanding of the global population
Need of correct primary healthcare infrastructure
The cytology and HPV testing market is segmented on the lines of its product , service and by geography. Based on product and service segmentation the cytology and HPV testing market covers HPV testing and cytology testing. HPV testing is further segmented into services, assay kits and system. Based on cytology testing segment the market covers services, assay kits and system. The cytology and HPV testing market covers the geographic segmentation in various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for cytology and HPV testing and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for cytology and HPV testing market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for various types of cytology and HPV testing market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Becton, Dickinson and Company, Cepheid, Inc., Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, Fujirebio Diagnostics, Inc., Arbor Vita Corporation, Hologic, Inc., QIAGEN N.V., and OncoHealth Corporation. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide the buyers with a snapshot of the industry’s most influential players.
The Cytology and HPV testing Market has been segmented as below:
By Product and Services Analysis
HPV Testing
Services
Assay kits
System
Cytology Testing
Services
Assay kits
System
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all cytology and HPV testing market globally.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of cytology and HPV testing data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
Chapter 1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
Chapter 2 Executive Summary
2.1 Global Cytology and HPV Testing Market, Estimates and Forecast, By Revenue, 2018–2024 (US$ Mn)
2.2 Global HPV Testing Market, by Product and Services, 2017 (US$ Mn)
2.3 Global Cytology Testing Market, by Product and Services, 2017 (US$ Mn)
2.4 Global Market Share by Geography, 2017 and 2024 (Value %)
2.5 Cytology and HPV Testing Market Snapshot
Chapter 3 Cytology and HPV Testing Market – Market Analysis
3.1 Introduction
3.2 Market Drivers
3.2.1 Rising incidence of cervical cancer worldwide
3.2.2 High incidence rate of HPV infections
3.2.3 Increasing cervical cancer screening awareness programs
3.3 Restraints
3.3.1 Lack of appropriate primary healthcare infrastructure
3.3.2 Low awareness of the global population hinders the growth of the market
3.4 Opportunity
3.4.1 Emerging economies to offer sustained growth opportunities
3.5 Market Attractiveness Analysis – Global Cytology and HPV Testing Market
3.6 Porter’s Five Forces Analysis
3.7 Competitive Landscape
3.7.1 Market Positioning of Key Players
3.7.2 Competitive Strategies adopted by Key Players
3.7.3 Recommendations
3.8 Epidemiology: HPV and Cervical Cancer
3.9 Market Segmentation – By Product and Services
3.9.1 Introduction – HPV Testing Market
3.9.2 Global HPV Testing Systems Market Revenue, (US$ Mn), 2018–2024
3.9.3 Global HPV Testing Assay Kits Market Revenue, (US$ Mn), 2018–2024
3.9.4 Global HPV Testing Services Market Revenue, (US$ Mn), 2018–2024
3.10 Market Segmentation – By Product and Services
3.10.1 Introduction – Cytology Testing
3.10.2 Global Cytology Testing Systems Market Revenue, (US$ Mn), 2018–2024
3.10.3 Global Cytology Testing Assay Kits Market Revenue, (US$ Mn), 2018–2024
3.10.4 Global Cytology Testing Services Market Revenue, (US$ Mn), 2018–2024
Chapter 4 Market Segmentation – By Region
4.1 North America Cytology and HPV Testing Market Revenue, (US$ Mn), 2018–2024
4.1.1 U.S.
4.1.2 Canada
4.2 Europe Cytology and HPV Testing Market Revenue, (US$ Mn), 2018–2024
4.2.1 Germany
4.2.2 France
4.2.3 U.K.
4.3 Asia Pacific Cytology and HPV Testing Market Revenue, (US$ Mn), 2018–2024
4.3.1 Japan
4.3.2 China
4.3.3 Australia
4.4 Rest of the World Cytology and HPV Testing Market Revenue, (US$ Mn), 2018–2024
4.4.1 Brazil
4.4.2 Mexico
4.4.3 RoW
Chapter 5 Company Profiles
5.1 Abbott Laboratories, Inc.
5.1.1 Company Overview
5.1.2 Financial Overview
5.1.3 Product Portfolio
5.1.4 Business Strategies
5.1.5 Recent Development
5.2 Arbor Vita Corporation
5.3 Becton, Dickinson and Company
5.4 Cepheid, Inc.
5.5 F. Hoffmann-La Roche Ltd.
5.6 Fujirebio Diagnostics, Inc.
5.7 Hologic, Inc.
5.8 OncoHealth Corporation
5.9 QIAGEN N.V
The Cytology and HPV testing Market has been segmented as below:
By Product and Services Analysis
HPV Testing
Services
Assay kits
System
Cytology Testing
Services
Assay kits
System
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
SUBSCRIBE TO OUR NEWSLETTERS
